Lifileucel

autologous tumor-infiltrating lymphocytes (TIL) therapy · Iovance Biotherapeutics

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Lifileucel, covering 2024-02-28 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma [Phase 2]